Adrenocortical tumorigenesis, luteinizing hormone receptor and transcription factors GATA-4 and GATA-6

Molecular and Cellular Endocrinology

Volumn 269, Issue 1-2 SPEC. ISS., 2007, Pages 38-45

  Vuorenoja, Susanna ^a   Rivero Muller, Adolfo ^a   Kiiveri, Sanne ^b   Bielinska, Malgorzata ^c   Heikinheimo, Markku ^b   Wilson, David B ^c   Huhtaniemi, Ilpo T ^a,d   Rahman, Nafis A ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c WASHINGTON UNIVERSITY   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Adrenal tumors; Gonadotropins; LHR; Transcription factors GATA 4 and GATA 6; Transgenic mice

Indexed keywords

LUTEINIZING HORMONE RECEPTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6; VIRUS ANTIGEN;

ADRENAL CORTEX TUMOR; ADRENAL GLAND; CARCINOGENESIS; DISEASE MODEL; GONADECTOMY; HORMONE ACTION; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIMIAN VIRUS 40; TRANSGENE; TRANSGENIC MOUSE;

EID: 33947607413     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.11.013     Document Type: Review

References (87)

1. Ahlman H., Khorram-Manesh A., Jansson S., Wangberg B., Nilsson O., Jacobsson C.E., and Lindstedt S. Cytotoxic treatment of adrenocortical carcinoma. World J. Surg. 25 (2001) 927-933
2. Alevizaki M., Saltiki K., Mantzou E., Anastasiou E., and Huhtaniemi I. The adrenal gland may be a target of LH action in postmenopausal women. Eur. J. Endocrinol. 154 (2006) 875-881
3. Anttonen M., Parviainen H., Kyronlahti A., Bielinska M., Wilson D.B., Ritvos O., and Heikinheimo M. GATA-4 is a granulosa cell factor employed in inhibin-alpha activation by the TGF-beta pathway. J. Mol. Endocrinol. 36 (2006) 557-568
4. Arceci R.J., King A.A., Simon M.C., Orkin S.H., and Wilson D.B. Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol. Cell. Biol. 13 (1993) 2235-2246
5. Arnaldi G., Masini A.M., Giacchetti G., Taccaliti A., Faloia E., and Mantero F. Adrenal incidentaloma. Braz. J. Med. Biol. Res. 33 (2000) 1177-1189
6. Barbosa A.S., Giacaglia L.R., Martin R.M., Mendonca B.B., and Lin C.J. Assessment of the role of transcript for GATA-4 as a marker of unfavorable outcome in human adrenocortical neoplasms. BMC Endocr. Disord. 4 (2004) 3
7. Bassett M.H., Mayhew B., Rehman K., White P.C., Mantero F., Arnaldi G., Stewart P.M., Bujalska I., and Rainey W.E. Expression profiles for steroidogenic enzymes in adrenocortical disease. J. Clin. Endocrinol. Metab. (2005)
8. Beuschlein F., Looyenga B.D., Bleasdale S.E., Mutch C., Bavers D.L., Parlow A.F., Nilson J.H., and Hammer G.D. Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Mol. Cell. Biol. 23 (2003) 3951-3964
9. Beuschlein F., Looyenga B.D., Reincke M., and Hammer G.D. Role of the inhibin/activin system and luteinizing hormone in adrenocortical tumorigenesis. Horm. Metab. Res. 36 (2004) 392-396
10. Bielinska M., Genova E., Boime I., Parviainen H., Kiiveri S., Leppaluoto J., Rahman N., Heikinheimo M., and Wilson D.B. Gonadotropin-induced adrenocortical neoplasia in NU/J nude mice. Endocrinology (2005)
11. Bielinska M., Genova E., Boime I., Parviainen H., Kiiveri S., Rahman N., Leppaluoto J., Heikinheimo M., and Wilson D.B. Nude mice as a model for gonadotropin-induced adrenocortical neoplasia. Endocr. Res. 30 (2004) 913-917
12. Bielinska M., Parviainen H., Porter-Tinge S.B., Kiiveri S., Genova E., Rahman N., Huhtaniemi I.T., Muglia L.J., Heikinheimo M., and Wilson D.B. Mouse strain susceptibility to gonadectomy-induced adrenocortical tumor formation correlates with the expression of GATA-4 and luteinizing hormone receptor. Endocrinology 144 (2003) 4123-4133
13. Bodek G., Rahman N.A., Zaleska M., Soliymani R., Lankinen H., Hansel W., Huhtaniemi I., and Ziecik A.J. A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate. Breast Cancer Res. Treat. 79 (2003) 1-10
14. Bodek G., Vierre S., Rivero-Muller A., Huhtaniemi I., Ziecik A.J., and Rahman N.A. A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice. Neoplasia 7 (2005) 497-508
15. Bornstein S.R., Stratakis C.A., and Chrousos G.P. Adrenocortical tumors: recent advances in basic concepts and clinical management. Ann. Intern. Med. 130 (1999) 759-771
16. Camper S.A., Saunders T.L., Kendall S.K., Keri R.A., Seasholtz A.F., Gordon D.F., Birkmeier T.S., Keegan C.E., Karolyi I.J., Roller M.L., et al. Implementing transgenic and embryonic stem cell technology to study gene expression, cell-cell interactions and gene function. Biol. Reprod. 52 (1995) 246-257
17. de Lange W.E., Pratt J.J., and Doorenbos H. A gonadotrophin responsive testosterone producing adrenocortical adenoma and high gonadotrophin levels in an elderly woman. Clin. Endocrinol. (Oxf.) 12 (1980) 21-28
18. Feelders R.A., Lamberts S.W., Hofland L.J., van Koetsveld P.M., Verhoef-Post M., Themmen A.P., de Jong F.H., Bonjer H.J., Clark A.J., van der Lely A.J., and de Herder W.W. Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro. J. Clin. Endocrinol. Metab. 88 (2003) 230-237
19. Feteke E., Wooley G., and Little C. Histological changes following ovariectomy in mice. J. Exp. Med. (1941) 1-8
20. Fluck C.E., and Miller W.L. GATA-4 and GATA-6 modulate tissue-specific transcription of the human gene for P450c17 by direct interaction with Sp1. Mol. Endocrinol. 18 (2004) 1144-1157
21. Franks S. Polycystic ovary syndrome. N. Engl. J. Med. 333 (1995) 853-861
22. Givens J.R., Andersen R.N., Wiser W.L., Donelson A.J., and Coleman S.A. A testosterone-secreting, gonadotropin-responsive pure thecoma and polycystic ovarian disease. J. Clin. Endocrinol. Metab. 41 (1975) 845-853
23. Hansel W., Leuschner C., Gawronska B., and Enright F. Targeted destruction of prostate cancer cells and xenografts by lytic peptide-betaLH conjugates. Reprod. Biol. 1 (2001) 20-32
24. Heikinheimo M., Ermolaeva M., Bielinska M., Rahman N.A., Narita N., Huhtaniemi I.T., Tapanainen J.S., and Wilson D.B. Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary. Endocrinology 138 (1997) 3505-3514
25. Heikinheimo M., Scandrett J.M., and Wilson D.B. Localization of transcription factor GATA-4 to regions of the mouse embryo involved in cardiac development. Dev. Biol. 164 (1994) 361-373
26. Jaffe R.B., Seron-Ferre M., Crickard K., Koritnik D., Mitchell B.F., and Huhtaniemi I.T. Regulation and function of the primate fetal adrenal gland and gonad. Recent Prog. Horm. Res. 37 (1981) 41-103
27. Jimenez P., Saner K., Mayhew B., and Rainey W.E. GATA-6 is expressed in the human adrenal and regulates transcription of genes required for adrenal androgen biosynthesis. Endocrinology 144 (2003) 4285-4288
28. Kananen K., Markkula M., Mikola M., Rainio E.M., McNeilly A., and Huhtaniemi I. Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin alpha- subunit gene. Mol. Endocrinol. 10 (1996) 1667-1677
29. Kananen K., Markkula M., Rainio E., Su J.G., Hsueh A.J., and Huhtaniemi I.T. Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin alpha-subunit promoter/simian virus T-antigen fusion gene: characterization of ovarian tumors and establishment of gonadotropin- responsive granulosa cell lines. Mol. Endocrinol. 9 (1995) 616-627
30. Kananen K., Rilianawati, Paukku T., Markkula M., Rainio E.M., and Huhtanemi I. Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene. Endocrinology 138 (1997) 3521-3531
31. Kero J., Poutanen M., Zhang F.P., Rahman N., McNicol A.M., Nilson J.H., Keri R.A., and Huhtaniemi I.T. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J. Clin. Invest. 105 (2000) 633-641
32. Ketola I., Otonkoski T., Pulkkinen M.A., Niemi H., Palgi J., Jacobsen C.M., Wilson D.B., and Heikinheimo M. Transcription factor GATA-6 is expressed in the endocrine and GATA-4 in the exocrine pancreas. Mol. Cell. Endocrinol. 226 (2004) 51-57
33. Ketola I., Pentikainen V., Vaskivuo T., Ilvesmaki V., Herva R., Dunkel L., Tapanainen J.S., Toppari J., and Heikinheimo M. Expression of transcription factor GATA-4 during human testicular development and disease. J. Clin. Endocrinol. Metab. 85 (2000) 3925-3931
34. Ketola I., Rahman N., Toppari J., Bielinska M., Porter-Tinge S.B., Tapanainen J.S., Huhtaniemi I.T., Wilson D.B., and Heikinheimo M. Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis. Endocrinology 140 (1999) 1470-1480
35. Kiiveri S., Liu J., Arola J., Heikkila P., Kuulasmaa T., Lehtonen E., Voutilainen R., and Heikinheimo M. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors. Mol. Cell. Endocrinol. 233 (2005) 47-56
36. Kiiveri S., Liu J., Heikkila P., Arola J., Lehtonen E., Voutilainen R., and Heikinheimo M. Transcription factors GATA-4 and GATA-6 in human adrenocortical tumors. Endocr. Res. 30 (2004) 919-923
37. Kiiveri S., Liu J., Westerholm-Ormio M., Narita N., Wilson D.B., Voutilainen R., and Heikinheimo M. Differential expression of GATA-4 and GATA-6 in fetal and adult mouse and human adrenal tissue. Endocrinology 143 (2002) 3136-3143
38. Kiiveri S., Liu J., Westerholm-Ormio M., Narita N., Wilson D.B., Voutilainen R., and Heikinheimo M. Transcription factors GATA-4 and GATA-6 during mouse and human adrenocortical development. Endocr. Res. 28 (2002) 647-650
39. Kiiveri S., Siltanen S., Rahman N., Bielinska M., Lehto V.P., Huhtaniemi I.T., Muglia L.J., Wilson D.B., and Heikinheimo M. Reciprocal changes in the expression of transcription factors GATA-4 and GATA-6 accompany adrenocortical tumorigenesis in mice and humans. Mol. Med. 5 (1999) 490-501
40. Kuo C.T., Morrisey E.E., Anandappa R., Sigrist K., Lu M.M., Parmacek M.S., Soudais C., and Leiden J.M. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 11 (1997) 1048-1060
41. Lacroix A., Hamet P., and Boutin J.M. Leuprolide acetate therapy in luteinizing hormone--dependent Cushing's syndrome. N. Engl. J. Med. 341 (1999) 1577-1581
42. Lassus H., Laitinen M.P., Anttonen M., Heikinheimo M., Aaltonen L.A., Ritvos O., and Butzow R. Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4. Lab. Invest. 81 (2001) 517-526
43. Latronico A.C., and Chrousos G.P. Extensive personal experience: adrenocortical tumors. J. Clin. Endocrinol. Metab. 82 (1997) 1317-1324
44. Latronico A.C., and Chrousos G.P. Neoplasms of the adrenal cortex. Clinical and basic aspects. Cancer Treat. Res. 89 (1997) 217-237
45. Laverriere A.C., MacNeill C., Mueller C., Poelmann R.E., Burch J.B., and Evans T. GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut. J. Biol. Chem. 269 (1994) 23177-23184
46. Leinonen P., Ranta T., Siegberg R., Pelkonen R., Heikkila P., and Kahri A. Testosterone-secreting virilizing adrenal adenoma with human chorionic gonadotrophin receptors and 21-hydroxylase deficiency. Clin. Endocrinol. (Oxf.) 34 (1991) 31-35
47. Lin L., Aggarwal S., Glover T.W., Orringer M.B., Hanash S., and Beer D.G. A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site-amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene. Cancer Res. 60 (2000) 1341-1347
48. Looyenga B., Beuschlein F., Nilson J., and Hammer G.D. Mechanistic roles of inhibin as a tumor suppressor in the adrenal cortex. Endocr. Res. 30 (2004) 585-586
49. Mantero F., and Arnaldi G. Management approaches to adrenal incidentalomas. A view from Ancona, Italy. Endocrinol. Metab. Clin. North Am. 29 (2000) 107-125 (ix)
50. Mantero F., Terzolo M., Arnaldi G., Osella G., Masini A.M., Ali A., Giovagnetti M., Opocher G., and Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 85 (2000) 637-644
51. Martin L.J., Taniguchi H., Robert N.M., Simard J., Tremblay J.J., and Viger R.S. Gata Factors and the nuclear receptors Sf-1/Lrh-1 are key mutual partners in the regulation of the human Hsd3b2 promoter. Mol. Endocrinol. (2005)
52. Matzuk M.M., Finegold M.J., Mather J.P., Krummen L., Lu H., and Bradley A. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8817-8821
53. Matzuk M.M., Kumar T.R., Shou W., Coerver K.A., Lau A.L., Behringer R.R., and Finegold M.J. Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Recent Prog. Horm. Res. 51 (1996) 123-154 (discussion 155-157)
54. Mazzuco T.L., Chabre O., Feige J.J., and Thomas M. Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features. J. Clin. Endocrinol. Metab. 91 (2006) 196-203
55. Michalkiewicz E.L., Sandrini R., Bugg M.F., Cristofani L., Caran E., Cardoso A.M., de Lacerda L., and Ribeiro R.C. Clinical characteristics of small functioning adrenocortical tumors in children. Med. Pediatr. Oncol. 28 (1997) 175-178
56. Mikola M., Rahman N., Paukku T., Ahtiainen P., and Huhtaniemi I.T. Gonadal tumors of mice double transgenic for inhibin alpha promoter driven Simian Virus 40 T-antigen are herpesSimplex Virus Thymidine Kinase are sensitive to Gancyclovir treatment. J. Endocrinol. 170 (2001) 79-90
57. Molkentin J.D., Lin Q., Duncan S.A., and Olson E.N. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 11 (1997) 1061-1072
58. Moolten F.L., and Wells J.M. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst. 82 (1990) 297-300
59. Moolten F.L., Wells J.M., Heyman R.A., and Evans R.M. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum. Gene Ther. 1 (1990) 125-134
60. Morrisey E.E., Ip H.S., Tang Z., and Parmacek M.S. GATA-4 activates transcription via two novel domains that are conserved within the GATA-4/5/6 subfamily. J. Biol. Chem. 272 (1997) 8515-8524
61. Morrisey E.E., Tang Z., Sigrist K., Lu M.M., Jiang F., Ip H.S., and Parmacek M.S. GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo. Genes Dev. 12 (1998) 3579-3590
62. Murphy K.J., and Rao A. Adrenal failure and relapse following treatment of systemic histoplasmosis. Med. J. Aust. 2 (1970) 27-28
63. Murthy A.S., Russfield A.B., and DeLisle M.P. Oxidative enzymes in postcastrational adrenal tumors of mice. Endocrinology 82 (1968) 989-994
64. Narita N., Heikinheimo M., Bielinska M., White R.A., and Wilson D.B. The gene for transcription factor GATA-6 resides on mouse chromosome 18 and is expressed in myocardium and vascular smooth muscle. Genomics 36 (1996) 345-348
65. Ng L., and Libertino J.M. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J. Urol. 169 (2003) 5-11
66. Orkin S.H. GATA-binding transcription factors in hematopoietic cells. Blood 80 (1992) 575-581
67. Pabon J.E., Li X., Lei Z.M., Sanfilippo J.S., Yussman M.A., and Rao C.V. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J. Clin. Endocrinol. Metab. 81 (1996) 2397-2400
68. Pehlivan T., Pober B.R., Brueckner M., Garrett S., Slaugh R., Van Rheeden R., Wilson D.B., Watson M.S., and Hing A.V. GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23,1 and congenital heart disease. Am. J. Med. Genet. 83 (1999) 201-206
69. Peterson II R.A., Kiupel M., Bielinska M., Kiiveri S., Heikinheimo M., Capen C.C., and Wilson D.B. Transcription factor GATA-4 is a marker of anaplasia in adrenocortical neoplasms of the domestic ferret (Mustela putorius furo). Vet. Pathol. 41 (2004) 446-449
70. Rahman N.A., Kananen Rilianawati K., Paukku T., Mikola M., Markkula M., Hamalainen T., and Huhtaniemi I.T. Transgenic mouse models for gonadal tumorigenesis. Mol. Cell. Endocrinol. 145 (1998) 167-174
71. Rahman N.A., Kiiveri S., Rivero-Muller A., Levallet J., Vierre S., Kero J., Wilson D.B., Heikinheimo M., and Huhtaniemi I. Adrenocortical tumorigenesis in transgenic mice expressing the inhibin alpha-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4. Mol. Endocrinol. 18 (2004) 2553-2569
72. Rao Ch V., Zhou X.L., and Lei Z.M. Functional luteinizing hormone/chorionic gonadotropin receptors in human adrenal cortical H295R cells. Biol. Reprod. 71 (2004) 579-587
73. Reincke M., Karl M., Travis W.H., Mastorakos G., Allolio B., Linehan H.M., and Chrousos G.P. p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J. Clin. Endocrinol. Metab. 78 (1994) 790-794
74. Rilianawati, Paukku T., Kero J., Zhang F.P., Rahman N., Kananen K., and Huhtaniemi I. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene. Mol. Endocrinol. 12 (1998) 801-809
75. Risma K.A., Clay C.M., Nett T.M., Wagner T., Yun J., and Nilson J.H. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 1322-1326
76. Rosner J.M., Charreau E., Houssay A.B., and Epper C. Biosynthesis of sexual steroids by hyperplastic adrenal glands of castrated female C3H/Ep mice. Endocrinology 79 (1966) 681-686
77. Sandrini R., Ribeiro R.C., and DeLacerda L. Childhood adrenocortical tumors. J. Clin. Endocrinol. Metab. 82 (1997) 2027-2031
78. Saner-Amigh K., Mayhew B.A., Mantero F., Schiavi F., White P.C., Rao C.V., and Rainey W.E. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. J. Clin. Endocrinol. Metab. 91 (2006) 1136-1142
79. Schulick R.D., and Brennan M.F. Adrenocortical carcinoma. World J. Urol. 17 (1999) 26-34
80. Sheeler L.R. Cushing's syndrome and pregnancy. Endocrinol. Metab. Clin. North Am. 23 (1994) 619-627
81. Tremblay J.J., and Viger R.S. A mutated form of steroidogenic factor 1 (SF-1 G35E) that causes sex reversal in humans fails to synergize with transcription factor GATA-4. J. Biol. Chem. 278 (2003) 42637-42642
82. Vassilopoulou-Sellin R., and Schultz P.N. Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer 92 (2001) 1113-1121
83. Wagner J., Portwine C., Rabin K., Leclerc J.M., Narod S.A., and Malkin D. High frequency of germline p53 mutations in childhood adrenocortical cancer. J. Natl. Cancer Inst. 86 (1994) 1707-1710
84. Wajchenberg B.L., Albergaria Pereira M.A., Medonca B.B., Latronico A.C., Campos Carneiro P., Alves V.A., Zerbini M.C., Liberman B., Carlos Gomes G., and Kirschner M.A. Adrenocortical carcinoma: clinical and laboratory observations. Cancer 88 (2000) 711-736
85. Wooley G., Feteke E., and Little C. Mammary tumor development in mice ovariectomized at birth. Proc. Natl. Acad. Sci. U.S.A. 25 (1939) 277-279
86. Wooley G., Feteke E., and Little C. Effect of castration in the dilute brown strain of mice. Endocrinology 28 (1941) 341-343
87. Wooley G., and Little C. The incidence of adrenal cortical carcinoma in gonadectomized female mice of the extreme dilutiuon strain. I. Observations on the adrenal cortex. Cancer Res. 5 (1945) 193-202